matched by medicine name — name-based until identifier coding refines it. Full protocol history →
https://shortagesignal.co.uk/medicine/lansoprazole
As of 05 Nov 2026 23:09 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Latest England noticeMSN/2026/044 Tier 2 · issued 07 Sep 2026 (59 days ago)
Expected backearly January 2027 as stated in the latest recorded notice stated window still aheadwindow end 10 Jan 2027, derived from “early January 2027”
ScotlandMSAN(2026)34 issued 16 Sep 2026 — NHS Scotland's own notice, matched by name; kept separate from England
Presentations, as stated in the latest recorded notice
Each line is re-expressed from MSN/2026/044 (07 Sep 2026): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| Lansoprazole 15mg and 30mg orodispersible tabletsaffected product · inferred from phrasing | Limited supply, as stated | early January 2027precision: early in the month · window end 10 Jan 2027, derived from “early January 2027” | notice of 07 Sep 2026 |
| Lansoprazole 15mg and 30mg gastro-resistant capsulesnamed by the source as remaining available · inferred from phrasing | Stated as available | — not stated for this line | notice of 07 Sep 2026 |
| Alternative proton pump inhibitorsclass-level statement by the source, not a named product · inferred from phrasing | Stated as available | — not stated for this line | notice of 07 Sep 2026 |
Protocol in force
matched by medicine name — name-based until identifier coding refines it. Full protocol history →
Named in the source as remaining available
- Lansoprazole 15mg and 30mg gastro-resistant capsules — named by the source as remaining available (inferred from phrasing)
Only names the source itself listed, as it listed them (source post ↗). No substitution, dosing or counselling advice is given here or implied.
Identifiers — Lansoprazole
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
One supply notification on record, 07 Sep 2026. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 07 Sep 2026 | Medicine Supply Notification: Lansoprazole 15mg and 30mg orodispersible tablets | Supply notification | Tier 2 | MSN/2026/044 |
Also recorded under
No other name appears in this medicine's notice titles. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.
- MSAN(2026)34 Lansoprazole 15mg and 30mg orodispersible tablets · issued 16 Sep 2026 · valid until early January 2027, as stated · matched by name PDF ↗